Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05724680
NCT05724680
Completed
Not Applicable

A Randomized Controlled Trial of the Effectiveness of Cognitive Behavior Therapy for Major Depression in Bangladesh

Rajshahi University1 site in 1 country148 target enrollmentAugust 10, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Rajshahi University
Enrollment
148
Locations
1
Primary Endpoint
Change in Depression Scale
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This was a randomized controlled clinical trial (RCT) carried out in three different hospitals in Dhaka city, Bangladesh.

Detailed Description

This was a randomized controlled trial, conducted to determine the effectiveness of CBT for depression delivered by trained therapists with an adapted Bengali CBT (BaCBT) manual, as compared to a control group. The main objective of the current study was to examine the efficacy of CBT for persons with major depression in Bangladesh.

Registry
clinicaltrials.gov
Start Date
August 10, 2018
End Date
May 30, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rajshahi University
Responsible Party
Principal Investigator
Principal Investigator

Dr. Jesan Ara

Associate Professor

Rajshahi University

Eligibility Criteria

Inclusion Criteria

  • •Diagnosed with Major Depression
  • •Must be able to take therapeutic session

Exclusion Criteria

  • •active suicidal ideation
  • •a co-morbid serious health condition
  • •with psychotic features
  • •currently on medication for depression
  • •with an intellectual disability

Outcomes

Primary Outcomes

Change in Depression Scale

Time Frame: change from baseline to day 42, a separate outcome from day 42 to day 72

Depression Scale to measure depression. The total scale scores range from 30 to 150. Higher scores mean worse outcomes.

Secondary Outcomes

  • Change in Anxiety Scale(change from baseline to day 42, a separate outcome from day 42 to day 72)
  • Change in General Health Questionnaire-28(change from baseline to day 42, a separate outcome from day 42 to day 72)
  • Change in Beck Scale for Suicidal Ideation(change from baseline to day 42, a separate outcome from day 42 to day 72)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
A multi-centre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagiarological and genital diseases: Menstrual disordersUrological and Genital DiseasesMenorrhagia
ISRCTN85619876Department of Health (UK)200
Completed
Phase 3
Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaDiabetic Macular Edema
NCT01572350Hospital Universitario de Canarias105
Completed
Phase 4
Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)Primary Adrenal InsufficiencySecondary Adrenal Insufficiency
NCT02277587University of Roma La Sapienza89
Completed
Not Applicable
Study to Analyze the Efficacy of Chronic Intake With a β-alanine Supplement in Recreational CyclistsBeta Alanine Supplementation
NCT06191055Universidad Católica San Antonio de Murcia75
Completed
Not Applicable
Clinical Trial on the Articular Pain of Diagnosed Patients of ArthrosisOsteoarthritis
NCT03525249Universidad Católica San Antonio de Murcia87